Should Ki-67 be adopted to select breast cancer patients for treatment with adjuvant abemaciclib?
Tarantino P, Burstein HJ, Lin NU, Krop IE, Winer EP, Schnitt SJ, Hamilton EP, Hurvitz SA, Rugo HS, Curigliano G, Tolaney SM.
Tarantino P, et al. Among authors: tolaney sm.
Ann Oncol. 2022 Mar;33(3):234-238. doi: 10.1016/j.annonc.2021.12.004. Epub 2021 Dec 20.
Ann Oncol. 2022.
PMID: 34942341
Free article.
No abstract available.